We are live on
!
Find out more
MLL
Moody Lynn & Lieberson Portfolio holdings
AUM
$1.9B
1-Year Est. Return
27.82%
This Fund
S&P 500
This Quarter
Est. Return
+8.39%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$937M
AUM Growth
+$115M
(+14%)
Cap. Flow
-$2.54M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
29.62%
Holding
230
New
21
Increased
73
Reduced
77
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$13.7M |
| 2 |
Biogen
BIIB
|
+$11.6M |
| 3 |
Illinois Tool Works
ITW
|
+$10.4M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$9.01M |
| 5 |
Citigroup
C
|
+$7.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$16.6M |
| 2 |
FRC
First Republic Bank
FRC
|
+$11.7M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$6.76M |
| 4 |
General Dynamics
GD
|
+$5.71M |
| 5 |
SPDR Gold Trust
GLD
|
+$5.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.83% |
| 2 | Industrials | 15.41% |
| 3 | Healthcare | 11.28% |
| 4 | Technology | 10.72% |
| 5 | Communication Services | 6.7% |
Similar funds
EP
SIC
DCP
OPCM
FTCM
RCA
IAN
VC
Moody Lynn & Lieberson's Q4 2017 Portfolio in Review
As of Q4 2017, Moody Lynn & Lieberson held 230 positions worth $937M, up 14% from $822M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Moody Lynn & Lieberson's Q4 2017 filing shows 21 new, 73 increased, 77 reduced and 23 closed positions. Its largest new stake was Biogen: 36,202 shares worth $12.8M. The largest sale was Celgene Corp, an estimated $16.6M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.
- Moody Lynn & Lieberson's largest Q4 2017 buy was Biogen: 36,202 shares worth $12.8M.
- Moody Lynn & Lieberson added most to Vanguard FTSE Emerging Markets ETF in Q4 2017, an estimated $13.7M increase.
- Moody Lynn & Lieberson's biggest Q4 2017 reduction was SPDR Gold Trust, cutting an estimated $5.55M.
- Moody Lynn & Lieberson fully exited Celgene Corp in Q4 2017, selling an estimated $16.6M.
- Moody Lynn & Lieberson's ten largest holdings make up 30% of its $937M portfolio in Q4 2017.
- Moody Lynn & Lieberson opened 21 new positions and closed 23 in Q4 2017.
- Moody Lynn & Lieberson's portfolio value rose 14% quarter-over-quarter to $937M.
Based on Moody Lynn & Lieberson's 13F filing for Q4 2017, filed 2 Feb 2018.